Thurston, Springer, Miller, Herd & Titak »

Alaunos Therapeutics shares owned by Thurston, Springer, Miller, Herd & Titak

Quarter-by-quarter ownership of Alaunos Therapeutics (TCRT) shares owned by Thurston, Springer, Miller, Herd & Titak from 13F filings

Historical chart of Thurston, Springer, Miller, Herd & Titak investment in Alaunos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics held by Thurston, Springer, Miller, Herd & Titak consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics by Thurston, Springer, Miller, Herd & Titak

Quarter filed Position value Share count Share price at filing
2025-06-30 $100 21 4.81
2025-03-31 $30 21 1.43
2024-12-31 $40 21 1.90

More positions owned by Thurston, Springer, Miller, Herd & Titak

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Eli Lilly & Co Common Stock (LLY)
Nvidia Corp Common Stock (NVDA)
Alps Etf Tr Etf Fund (OUSA)
Oracle Corporation Common Stock (ORCL)
First Trust Rising Etf Fund (RDVY)
Broadcom Common Stock (AVGO)
Berkshire Hathaway Common Stock (BRK.B)
Amazon Common Stock (AMZN)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Growth Etf Fund (VUG)
Tesla Common Stock (TSLA)
Vanguard Index Fds Etf Fund (VOO)
Alphabet Inc Non Voting Common Stock (GOOG)

View all positions for Thurston, Springer, Miller, Herd & Titak

Top funds holding Alaunos Therapeutics

Vanguard Group
BlackRock
Geode Capital Management
Tower Research Capital
UBS Group
Advisor Group Holdings
Atlantic Trust
Royal Bank of Canada
Wells Fargo & Company
Ronald Blue Trust
Steward Partners Investment Advisory
Federation des caisses Desjardins du Quebec
Barclays
Newbridge Financial Services Group
Key FInancial

View all funds holding Alaunos Therapeutics